Acerinox Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Acerinox wird ein jährliches Gewinn- und Umsatzwachstum von 26.3% bzw. 7.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 25.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17% betragen.
Wichtige Informationen
39.2%
Wachstumsrate der Gewinne
38.7%
EPS-Wachstumsrate
Metals and Mining Gewinnwachstum | 33.6% |
Wachstumsrate der Einnahmen | 10.2% |
Zukünftige Eigenkapitalrendite | 13.9% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 18 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Acerinox, S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 27Acerinox, S.A. (BME:ACX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Apr 29Recent updates
Are Investors Undervaluing Acerinox, S.A. (BME:ACX) By 32%?
Sep 09Acerinox, S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 27Is Acerinox (BME:ACX) Using Too Much Debt?
Jun 27Acerinox, S.A. (BME:ACX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Apr 29A Piece Of The Puzzle Missing From Acerinox, S.A.'s (BME:ACX) Share Price
Apr 04These 4 Measures Indicate That Acerinox (BME:ACX) Is Using Debt Extensively
Dec 18Calculating The Fair Value Of Acerinox, S.A. (BME:ACX)
Nov 10These 4 Measures Indicate That Acerinox (BME:ACX) Is Using Debt Extensively
Sep 09Does This Valuation Of Acerinox, S.A. (BME:ACX) Imply Investors Are Overpaying?
Jul 30These 4 Measures Indicate That Acerinox (BME:ACX) Is Using Debt Reasonably Well
Apr 18Does This Valuation Of Acerinox, S.A. (BME:ACX) Imply Investors Are Overpaying?
Mar 31Are Acerinox, S.A. (BME:ACX) Investors Paying Above The Intrinsic Value?
Dec 17We Think Acerinox (BME:ACX) Can Stay On Top Of Its Debt
Nov 22An Intrinsic Calculation For Acerinox, S.A. (BME:ACX) Suggests It's 33% Undervalued
Sep 07Is Acerinox (BME:ACX) Using Too Much Debt?
Jul 30Acerinox, S.A. (BME:ACX) Shares Could Be 24% Below Their Intrinsic Value Estimate
May 27These 4 Measures Indicate That Acerinox (BME:ACX) Is Using Debt Reasonably Well
Apr 15A Look At The Fair Value Of Acerinox, S.A. (BME:ACX)
Feb 09Is Acerinox (BME:ACX) Using Too Much Debt?
Dec 28Acerinox, S.A. (BME:ACX) Shares Could Be 34% Below Their Intrinsic Value Estimate
Oct 25Are Investors Undervaluing Acerinox, S.A. (BME:ACX) By 20%?
Jul 25Acerinox (BME:ACX) Seems To Use Debt Quite Sensibly
Jun 14Should You Or Shouldn't You: A Dividend Analysis on Acerinox, S.A. (BME:ACX)
Apr 11Acerinox's (BME:ACX) Solid Earnings Have Been Accounted For Conservatively
Mar 06Does Acerinox (BME:ACX) Have A Healthy Balance Sheet?
Feb 20What Type Of Shareholders Make Up Acerinox, S.A.'s (BME:ACX) Share Registry?
Jan 27Acerinox's (BME:ACX) Stock Price Has Reduced 22% In The Past Three Years
Jan 07Should You Buy Acerinox, S.A. (BME:ACX) For Its Dividend?
Dec 16Don't Race Out To Buy Acerinox, S.A. (BME:ACX) Just Because It's Going Ex-Dividend
Nov 25We Think Acerinox (BME:ACX) Is Taking Some Risk With Its Debt
Nov 18Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 7,508 | 396 | 376 | 571 | 10 |
12/31/2025 | 7,137 | 368 | 321 | 528 | 12 |
12/31/2024 | 5,972 | 253 | 237 | 463 | 12 |
6/30/2024 | 5,869 | 65 | 667 | 824 | N/A |
3/31/2024 | 6,315 | 145 | 521 | 688 | N/A |
12/31/2023 | 6,616 | 228 | 307 | 481 | N/A |
9/30/2023 | 6,799 | 163 | 552 | 738 | N/A |
6/30/2023 | 7,421 | 225 | 205 | 391 | N/A |
3/31/2023 | 8,211 | 426 | 293 | 451 | N/A |
12/31/2022 | 8,716 | 556 | 407 | 544 | N/A |
9/30/2022 | 8,935 | 940 | 118 | 231 | N/A |
6/30/2022 | 8,464 | 978 | 260 | 357 | N/A |
3/31/2022 | 7,554 | 760 | 344 | 439 | N/A |
12/31/2021 | 6,708 | 572 | 286 | 388 | N/A |
9/30/2021 | 5,989 | 391 | 347 | 438 | N/A |
6/30/2021 | 5,406 | 250 | 352 | 453 | N/A |
3/31/2021 | 4,953 | 99 | 373 | 480 | N/A |
12/31/2020 | 4,671 | 49 | 319 | 421 | N/A |
9/30/2020 | 4,551 | -142 | 181 | 308 | N/A |
6/30/2020 | 4,651 | -127 | 200 | 330 | N/A |
3/31/2020 | 4,718 | -65 | N/A | N/A | N/A |
12/31/2019 | 4,761 | -60 | 213 | 359 | N/A |
9/30/2019 | 4,818 | 129 | 242 | 387 | N/A |
6/30/2019 | 4,880 | 168 | 147 | 299 | N/A |
3/31/2019 | 4,977 | 212 | N/A | N/A | N/A |
12/31/2018 | 5,029 | 237 | 180 | 326 | N/A |
9/30/2018 | 5,005 | 298 | 150 | 295 | N/A |
6/30/2018 | 4,789 | 221 | 262 | 430 | N/A |
3/31/2018 | 4,645 | 194 | N/A | N/A | N/A |
12/31/2017 | 4,644 | 234 | N/A | 366 | N/A |
9/30/2017 | 4,571 | 193 | N/A | 343 | N/A |
6/30/2017 | 4,509 | 222 | N/A | 181 | N/A |
3/31/2017 | 4,274 | 187 | N/A | 301 | N/A |
12/31/2016 | 3,975 | 80 | N/A | 269 | N/A |
9/30/2016 | 3,839 | 32 | N/A | 244 | N/A |
6/30/2016 | 3,828 | -12 | N/A | 315 | N/A |
3/31/2016 | 4,049 | 4 | N/A | 263 | N/A |
12/31/2015 | 4,240 | 43 | N/A | 17 | N/A |
9/30/2015 | 4,417 | 58 | N/A | N/A | N/A |
6/30/2015 | 4,544 | 124 | N/A | 170 | N/A |
3/31/2015 | 4,517 | 142 | N/A | 66 | N/A |
12/31/2014 | 4,396 | 136 | N/A | 50 | N/A |
9/30/2014 | 4,263 | 149 | N/A | 144 | N/A |
6/30/2014 | 4,095 | 82 | N/A | 92 | N/A |
3/31/2014 | 3,994 | 32 | N/A | 176 | N/A |
12/31/2013 | 4,006 | 22 | N/A | 259 | N/A |
9/30/2013 | 4,098 | -20 | N/A | 496 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ACXDas prognostizierte Gewinnwachstum (26.3% pro Jahr) liegt über der Sparquote (1.5%).
Ertrag vs. Markt: ACXDie Erträge des Unternehmens (26.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (9.4% pro Jahr).
Hohe Wachstumserträge: ACXEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: ACXDie Einnahmen des Unternehmens (7.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (4.7% pro Jahr).
Hohe Wachstumseinnahmen: ACXDie Einnahmen des Unternehmens (7.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ACXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (17%).